Arkolith/Insider Trading/TLSI/Form 4

Wahlstrom Mats

Director, 10% OwnerTriSalus Life Sciences, Inc. (TLSI) · full profile →Form 4 · filed Nov 22, 2024
Net Buying
Open-Market Buys
$47K
Open-Market Sells
$0
Net Open-Market Flow
$47K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 21, 2024Buy(P)9K$4.44$39K11K
Nov 20, 2024Buy(P)2K$4.16$8K2K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-027587) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML